Home » NIH Grants $12.8M to Vanderbilt for Pharmacogenomics

NIH Grants $12.8M to Vanderbilt for Pharmacogenomics

Jul 10, 2015
|
staff reporter

NEW YORK (GenomeWeb) –Vanderbilt University Medical Center yesterday announced it has received a five-year $12.8 million grant from the National Institutes of Health for a new phamacogenomics research center.

Vanderbilit received the so-called "P50" grant from the National Institute of General Medical Sciences' Pharmacogenomics Research Network (PGRN) to establish a specialized research center for pharmacogenomics and personalized medicine.

Vanderbilt faculty members Dan Roden, Josh Denny, and Elizabeth Phillips are the co-principal investigators for the grant.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Scan

Here We Are Again

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

In the Pink

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

All Tied Up in a Bow

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

This Week in PNAS

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.

What's Popular?

In Research Funding

  1. VC Aspire Universal Forms Personalized Medicine Investment Fund

  2. Chan Zuckerberg Initiative to Fund Human Cell Atlas Projects

Sponsorships

Privacy Policy.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.